# Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

> **NCT00127270** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 395 (actual)

## Conditions studied

- Urinary Incontinence

## Interventions

- **DRUG:** Darifenacin
- **DRUG:** Darifenacin
- **BEHAVIORAL:** Behavioral therapy

## Key facts

- **NCT ID:** NCT00127270
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 395 (ACTUAL)
- **Last updated:** 2008-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127270, "Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00127270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*